• Home
  • Pharmaceuticals and Healthcare
Global Companion Diagnostics Market Opportunities and Forecast 2022-2028

Global Companion Diagnostics Market Opportunities and Forecast 2022-2028

Report Code: KNJ1313210 | No. of Pages: 129 | Category: Pharmaceuticals and Healthcare
Publisher: GRD Survey | Date of Publish: May-2022 
This report provides a comprehensive analysis of current global Companion Diagnostics market based on segmented types and downstream applications. Major product development trends are discussed  under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Companion Diagnostics industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

According to GRD Survey, the global Companion Diagnostics market is estimated at $  million in 2021, and projected to grow at a CAGR of % to $  million by 2028.

Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Companion Diagnostics Market Opportunities and Forecast 2023-2028 report makes a brilliant attempt to unveil key opportunities available in the global Companion Diagnostics market under the Covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

The Global Companion Diagnostics Market has been exhibited in detail in the following chapters
Chapter 1 displays the basic product introduction and market overview.
Chapter 2 provides the competition landscape of global Companion Diagnostics industry. 
Chapter 3 provides the market analysis by type and by region
Chapter 4 provides the market analysis by application and by region
Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis. 
Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
Chapter 12 provides the market forecast by type and by application
Chapter 13 provides the market forecast by region
Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
Chapter 15 conclusions

Segmented by Type
    Polymerase Chain Reaction (PCR)

    Immunohistochemistry (IHC)

    In Situ Hybridization (ISH)

    Next Generation Sequencing (NGS)

Segmented by Application
    Hospitals

    Pharmaceutical Companies

    Laboratories

    Other

Segmented by Country
    North America
        United States
        Canada
        Mexico
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
    Asia Pacific
        China
        Japan
        Korea
        Southeast Asia
        India
        Australasia
    Central & South America
        Brazil
        Argentina
        Colombia
    Middle East & Africa
        Iran
        Israel
        Turkey
        South Africa
        Saudi Arabia

Key manufacturers included in this survey
    Thermo Fisher Scientific

    Roche Holdings

    Qiagen

    Myriad Genetics

    Life Technologies

    Genomic Health

    GE Healthcare

    Danaher

    Applied Proteomics

    Agilent Technologies

    Agendia

    Advanced Cell Diagnostics

    Abbott Laboratories



Table of Contents

1 Product Introduction and Overview
    1.1 Product Definition
    1.2 Product Specification
    1.3 Global Market Overview
        1.3.1 Global Companion Diagnostics Market Status and Forecast (2017-2028)
        1.3.2 Global Companion Diagnostics Sales Value CAGR by Region
    1.4 Market Drivers, Inhibitors
        1.4.1 Market Drivers
        1.4.2 Market Inhibitors
        1.4.3 COVID-19 Impact Analysis
2 Global Companion Diagnostics Supply by Company
    2.1 Global Companion Diagnostics Sales Value by Company
    2.2 Companion Diagnostics Sales Area of Main Manufacturers
    2.3 Trend of Concentration Rate
3 Global and Regional Companion Diagnostics Market Status by Type
    3.1 Companion Diagnostics Type Introduction
        3.1.1 Polymerase Chain Reaction (PCR)

        3.1.2 Immunohistochemistry (IHC)

        3.1.3 In Situ Hybridization (ISH)

        3.1.4 Next Generation Sequencing (NGS)
    3.2 Global Companion Diagnostics Market by Type
    3.3 North America: by Type
    3.4 Europe: by Type
    3.5 Asia Pacific: by Type
    3.6 Central & South America: by Type
    3.7 Middle East & Africa: by Type
4 Global and Regional Companion Diagnostics Market Status by Application
    4.1 Companion Diagnostics Segment by Application
        4.1.1 Hospitals

        4.1.2 Pharmaceutical Companies

        4.1.3 Laboratories

        4.1.4 Other
    4.2 Global Companion Diagnostics Market by Application
    4.3 North America: by Application
    4.4 Europe: by Application
    4.5 Asia Pacific: by Application
    4.6 Central & South America: by Application
    4.7 Middle East & Africa: by Application
5 Global Companion Diagnostics Market Status by Region
    5.1 Global Companion Diagnostics Market by Region
    5.2 North America Companion Diagnostics Market Status
    5.3 Europe Companion Diagnostics Market Status
    5.4 Asia Pacific Companion Diagnostics Market Status
    5.5 Central & South America Companion Diagnostics Market Status
    5.6 Middle East & Africa Companion Diagnostics Market Status
6 North America Companion Diagnostics Market Status
    6.1 North America Companion Diagnostics Market by Country
    6.2 United States
    6.3 Canada
    6.4 Mexico
7 Europe Companion Diagnostics Market Status
    7.1 Europe Companion Diagnostics Market by Country
    7.2 Germany
    7.3 France
    7.4 UK
    7.5 Italy
    7.6 Russia
    7.7 Spain
8 Asia Pacific Companion Diagnostics Market Status
   8.1 Asia Pacific Companion Diagnostics Market by Country
    8.2 China
    8.3 Japan
    8.4 Korea
    8.5 Southeast Asia
    8.6 India
    8.7 Australasia
9 Central & South America Companion Diagnostics Market Status
    9.1 Central & South America Companion Diagnostics Market by Country
    9.2 Brazil
    9.3 Argentina
    9.4 Colombia
10 Middle East & Africa Companion Diagnostics Market Status
    10.1 Middle East & Africa Companion Diagnostics Market by Country
    10.2 Iran
    10.3 Israel
    10.4 Turkey
    10.5 South Africa
    10.8 Saudi Arabia
11 Major Downstream Customers Analysis
    11.1 Customer One Analysis
    11.2 Customer Two Analysis
    11.3 Customer Three Analysis
    11.4 Customer Four Analysis
12 Global Companion Diagnostics Market Forecast by Type and by Application
    12.1 Global Companion Diagnostics Sales Value Forecast (2023-2028)
    12.2 Global Companion Diagnostics Forecast by Type
    12.3 Global Companion Diagnostics Forecast by Application
13 Global Companion Diagnostics Market Forecast by Region/Country
    13.1 Global Companion Diagnostics Market Forecast by Region (2023-2028)
    13.2 North America Market Forecast
    13.3 Europe Market Forecast
    13.4 Asia Pacific Market Forecast
    13.5 Central & South America Market Forecast
    13.6 Middle East & Africa Market Forecast
14 Key Participants Company Information
    14.1 Thermo Fisher Scientific

        14.1.1 Company Information
        14.1.2 Companion Diagnostics Product Introduction
        14.1.3 Thermo Fisher Scientific
 Companion Diagnostics Sales Value, Gross Margin and Global Share (2020-2022)
        14.1.4 SWOT Analysis
    14.2 Roche Holdings

        14.2.1 Company Information
        14.2.2 Companion Diagnostics Product Introduction
        14.2.3 Roche Holdings
 Companion Diagnostics Sales Value, Gross Margin and Global Share (2020-2022)
        14.2.4 SWOT Analysis
    14.3 Qiagen

        14.3.1 Company Information
        14.3.2 Companion Diagnostics Product Introduction
        14.3.3 Qiagen
 Companion Diagnostics Sales Value, Gross Margin and Global Share (2020-2022)
        14.3.4 SWOT Analysis
    14.4 Myriad Genetics

        14.4.1 Company Information
        14.4.2 Companion Diagnostics Product Introduction
        14.4.3 Myriad Genetics
 Companion Diagnostics Sales Value, Gross Margin and Global Share (2020-2022)
        14.4.4 SWOT Analysis
    14.5 Life Technologies

        14.5.1 Company Information
        14.5.2 Companion Diagnostics Product Introduction
        14.5.3 Life Technologies
 Companion Diagnostics Sales Value, Gross Margin and Global Share (2020-2022)
        14.5.4 SWOT Analysis
    14.6 Genomic Health

        14.6.1 Company Information
        14.6.2 Companion Diagnostics Product Introduction
        14.6.3 Genomic Health
 Companion Diagnostics Sales Value, Gross Margin and Global Share (2020-2022)
        14.6.4 SWOT Analysis
    14.7 GE Healthcare

        14.7.1 Company Information
        14.7.2 Companion Diagnostics Product Introduction
        14.7.3 GE Healthcare
 Companion Diagnostics Sales Value, Gross Margin and Global Share (2020-2022)
        14.7.4 SWOT Analysis
    14.8 Danaher

        14.8.1 Company Information
        14.8.2 Companion Diagnostics Product Introduction
        14.8.3 Danaher
 Companion Diagnostics Sales Value, Gross Margin and Global Share (2020-2022)
        14.8.4 SWOT Analysis
    14.9 Applied Proteomics

        14.9.1 Company Information
        14.9.2 Companion Diagnostics Product Introduction
        14.9.3 Applied Proteomics
 Companion Diagnostics Sales Value, Gross Margin and Global Share (2020-2022)
        14.9.4 SWOT Analysis
    14.10 Agilent Technologies

        14.10.1 Company Information
        14.10.2 Companion Diagnostics Product Introduction
        14.10.3 Agilent Technologies
 Companion Diagnostics Sales Value, Gross Margin and Global Share (2020-2022)
        14.10.4 SWOT Analysis
    14.11 Agendia

    14.12 Advanced Cell Diagnostics

    14.13 Abbott Laboratories

15 Conclusion
16 Methodology

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com